...
spro-img

Spero Therapeutics Inc, Common Stock

SPRO

NSQ

$1.07

-$0.03

(-2.73%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$62.70M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
13.75
Volume info-icon
This is the total number of shares traded during the most recent trading day.
192.19K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.01 L
$1.89 H
$1.07

About Spero Therapeutics Inc, Common Stock

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSPROSectorS&P500
1-Week Return-8.55%-2.27%-0.57%
1-Month Return-18.32%-3.96%1.21%
3-Month Return-21.9%-9.7%7.57%
6-Month Return-21.9%-3.37%11.45%
1-Year Return-17.05%3.71%28.48%
3-Year Return-92.16%3.8%29.52%
5-Year Return-90.35%39.78%90.66%
10-Year Return-90.7%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue4.74M9.33M18.26M48.58M96.73M[{"date":"2019-12-31","value":4.9,"profit":true},{"date":"2020-12-31","value":9.64,"profit":true},{"date":"2021-12-31","value":18.87,"profit":true},{"date":"2022-12-31","value":50.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue65.78M67.00M1.12M1.55M367.00K[{"date":"2019-12-31","value":98.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":1.67,"profit":true},{"date":"2022-12-31","value":2.31,"profit":true},{"date":"2023-12-31","value":0.55,"profit":true}]
Gross Profit4.74M9.33M17.14M47.03M96.37M[{"date":"2019-12-31","value":4.92,"profit":true},{"date":"2020-12-31","value":9.68,"profit":true},{"date":"2021-12-31","value":17.78,"profit":true},{"date":"2022-12-31","value":48.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin100.00%100.00%93.88%96.82%99.62%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.88,"profit":true},{"date":"2022-12-31","value":96.82,"profit":true},{"date":"2023-12-31","value":99.62,"profit":true}]
Operating Expenses67.96M88.44M106.23M79.15M75.25M[{"date":"2019-12-31","value":63.97,"profit":true},{"date":"2020-12-31","value":83.26,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.51,"profit":true},{"date":"2023-12-31","value":70.84,"profit":true}]
Operating Income(63.22M)(79.11M)(87.97M)(42.20M)21.48M[{"date":"2019-12-31","value":-294.29,"profit":false},{"date":"2020-12-31","value":-368.29,"profit":false},{"date":"2021-12-31","value":-409.53,"profit":false},{"date":"2022-12-31","value":-196.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense3.62M1.23M(3.38M)(5.72M)7.86M[{"date":"2019-12-31","value":46.04,"profit":true},{"date":"2020-12-31","value":15.7,"profit":true},{"date":"2021-12-31","value":-42.99,"profit":false},{"date":"2022-12-31","value":-72.74,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(60.92M)(78.28M)(89.76M)(46.41M)25.40M[{"date":"2019-12-31","value":-239.82,"profit":false},{"date":"2020-12-31","value":-308.14,"profit":false},{"date":"2021-12-31","value":-353.31,"profit":false},{"date":"2022-12-31","value":-182.71,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(750.00K)(761.00K)1.54M1.61M2.60M[{"date":"2019-12-31","value":-28.87,"profit":false},{"date":"2020-12-31","value":-29.29,"profit":false},{"date":"2021-12-31","value":59.47,"profit":true},{"date":"2022-12-31","value":62.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(60.17M)(77.52M)(91.30M)(48.03M)22.81M[{"date":"2019-12-31","value":-263.86,"profit":false},{"date":"2020-12-31","value":-339.91,"profit":false},{"date":"2021-12-31","value":-400.34,"profit":false},{"date":"2022-12-31","value":-210.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(60.92M)(78.28M)(89.76M)(46.41M)22.81M[{"date":"2019-12-31","value":-267.14,"profit":false},{"date":"2020-12-31","value":-343.24,"profit":false},{"date":"2021-12-31","value":-393.56,"profit":false},{"date":"2022-12-31","value":-203.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(60.17M)(77.52M)(91.30M)(48.03M)22.81M[{"date":"2019-12-31","value":-263.86,"profit":false},{"date":"2020-12-31","value":-339.91,"profit":false},{"date":"2021-12-31","value":-400.34,"profit":false},{"date":"2022-12-31","value":-210.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)(3.30)(3.58)(2.89)(1.66)0.52[{"date":"2019-12-31","value":-634.62,"profit":false},{"date":"2020-12-31","value":-688.46,"profit":false},{"date":"2021-12-31","value":-555.77,"profit":false},{"date":"2022-12-31","value":-319.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SPRO
Cash Ratio 1.55
Current Ratio 2.68

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SPRO
ROA (LTM) 10.48%
ROE (LTM) 25.81%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SPRO
Debt Ratio Lower is generally better. Negative is bad. 0.52
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.48

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SPRO
Trailing PE 13.38
Forward PE NM
P/S (TTM) 0.49
P/B 0.89
Price/FCF 5
EV/R 0.14
EV/Ebitda 0.75
PEG NM

FAQs

What is Spero Therapeutics Inc share price today?

Spero Therapeutics Inc (SPRO) share price today is $1.07

Can Indians buy Spero Therapeutics Inc shares?

Yes, Indians can buy shares of Spero Therapeutics Inc (SPRO) on Vested. To buy Spero Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SPRO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Spero Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Spero Therapeutics Inc (SPRO) via the Vested app. You can start investing in Spero Therapeutics Inc (SPRO) with a minimum investment of $1.

How to invest in Spero Therapeutics Inc shares from India?

You can invest in shares of Spero Therapeutics Inc (SPRO) via Vested in three simple steps:

  • Click on Sign Up or Invest in SPRO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Spero Therapeutics Inc shares
What is Spero Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Spero Therapeutics Inc (SPRO) is $1.89. The 52-week low price of Spero Therapeutics Inc (SPRO) is $1.01.

What is Spero Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Spero Therapeutics Inc (SPRO) is 13.75

What is Spero Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Spero Therapeutics Inc (SPRO) is 0.89

What is Spero Therapeutics Inc dividend yield?

The dividend yield of Spero Therapeutics Inc (SPRO) is 0.00%

What is the Market Cap of Spero Therapeutics Inc?

The market capitalization of Spero Therapeutics Inc (SPRO) is $62.70M

What is Spero Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Spero Therapeutics Inc is SPRO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top